bf/NASDAQ:RIGL_icon.jpeg

NASDAQ:RIGL

Rigel Pharmaceuticals, Inc.

  • Stock

USD

Last Close

10.90

26/07 20:00

Market Cap

150.83M

Beta: 0.73

Volume Today

58.14K

Avg: 2.73M

PE Ratio

−8.04

PFCF: −5.71

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-89.03M
-
-90.91M
2.11%
-51.46M
43.39%
-69.22M
34.49%
-77.99M
12.68%
-70.48M
9.63%
-66.89M
5.09%
-29.74M
55.54%
-17.91M
39.77%
-58.57M
226.97%
-25.09M
57.16%
depreciation and amortization
2.59M
-
2.36M
8.99%
1.44M
39.00%
941K
34.61%
465K
50.58%
594K
27.74%
683K
14.98%
706K
3.37%
1.16M
64.59%
998K
14.11%
1.24M
24.05%
deferred income tax
-98K
-
27K
-
-1.08M
4,107.41%
287K
-
-10.58M
-
stock based compensation
7.17M
-
9.79M
36.58%
7.40M
24.36%
7.33M
0.95%
5.99M
18.36%
7.70M
28.68%
9.12M
18.32%
7.30M
19.95%
9.49M
30.00%
12.38M
30.56%
8.81M
28.90%
change in working capital
-6.79M
-
-195K
97.13%
19.27M
9,980%
-15.79M
181.97%
-5.43M
65.62%
4.12M
175.91%
16.66M
304.15%
-30.32M
282.02%
9.72M
132.05%
-29.05M
398.92%
9.52M
132.76%
accounts receivables
-5.75M
-
5.55M
-
203K
96.34%
-4.08M
-
-6.03M
48.00%
-5.86M
2.85%
501K
108.55%
-24.85M
5,059.68%
9.77M
139.32%
inventory
1.37M
-
801K
-
2.09M
161.17%
-839K
-
-366K
56.38%
-126K
65.57%
-4.88M
3,769.05%
-2.38M
51.24%
1.17M
149.31%
accounts payables
2.21M
-
-2.29M
203.81%
1.15M
150.22%
2.80M
143.48%
-2.95M
205.25%
3.75M
227.42%
-2.24M
159.63%
-331K
85.22%
41K
112.39%
3.79M
9,139.02%
-366K
109.66%
other working capital
-4.61M
-
2.10M
145.41%
11.77M
461.72%
-20.89M
277.49%
-2.48M
88.11%
5.28M
312.77%
25.30M
378.86%
-24.00M
194.88%
14.05M
158.54%
-5.61M
139.94%
-1.06M
81.13%
other non cash items
9.30M
-
-57K
100.61%
818K
1,535.09%
495K
39.49%
-766K
254.75%
-1.07M
40.08%
-122K
88.63%
3.14M
2,672.95%
481K
84.68%
10.36M
2,054.47%
net cash provided by operating activities
-86.06M
-
-69.75M
18.95%
-23.41M
66.43%
-75.89M
224.13%
-77.56M
2.20%
-58.83M
24.15%
-41.51M
29.44%
-52.19M
25.72%
5.88M
111.26%
-73.76M
1,354.81%
-5.74M
92.21%
investments in property plant and equipment
-1.22M
-
-413K
66.18%
-546K
32.20%
-804K
47.25%
-164K
79.60%
-1.11M
574.39%
-1.46M
31.56%
-1.26M
13.26%
-627K
50.32%
-450K
28.23%
-15M
3,233.33%
acquisitions net
1.22M
-
1.11M
-
1.46M
31.56%
1.26M
13.26%
627K
50.32%
893K
42.42%
259K
71.00%
purchases of investments
-308.85M
-
-218.59M
29.22%
-151.76M
30.57%
-103.05M
32.10%
-116.86M
13.40%
-78.00M
33.26%
-145.33M
86.33%
-81.71M
43.78%
-141.46M
73.13%
-28.89M
79.57%
-31.21M
8.00%
sales maturities of investments
382.45M
-
281.70M
26.34%
196.86M
30.12%
128.65M
34.65%
96.82M
24.74%
104.07M
7.48%
123.13M
18.32%
130.43M
5.94%
62.05M
52.43%
101.23M
63.14%
41.65M
58.86%
other investing activites
-1.22M
-
234K
119.16%
60K
74.36%
88K
46.67%
732K
731.82%
-1.11M
251.09%
-1.46M
31.56%
-1.26M
13.26%
-627K
50.32%
net cash used for investing activites
72.38M
-
62.93M
13.05%
44.61M
29.11%
24.88M
44.23%
-19.47M
178.26%
24.96M
228.20%
-23.66M
194.76%
47.47M
300.65%
-80.04M
268.62%
72.78M
190.93%
-4.30M
105.90%
debt repayment
-9.79M
-
-9.97M
1.90%
-57.90M
480.45%
-4.43M
92.36%
-17.32M
291.28%
common stock issued
1.05M
-
1.17M
11.32%
5.29M
352.31%
23.59M
345.69%
114.18M
384.10%
67.16M
41.18%
1.58M
97.65%
2.60M
64.72%
4.78M
83.94%
2.12M
55.52%
1.05M
50.61%
common stock repurchased
dividends paid
other financing activites
1.76M
-
1.60M
9.26%
3.51M
119.52%
4.73M
34.89%
19.58M
313.74%
19.95M
1.90%
115.80M
480.45%
8.85M
92.36%
34.64M
291.28%
net cash used provided by financing activities
1.05M
-
1.17M
11.32%
7.05M
502.82%
25.18M
257.07%
117.69M
367.31%
71.89M
38.91%
11.37M
84.19%
12.57M
10.61%
62.67M
398.57%
6.55M
89.55%
18.37M
180.41%
effect of forex changes on cash
net change in cash
-12.63M
-
-5.65M
55.26%
28.25M
599.96%
-25.82M
191.40%
20.66M
180.00%
38.03M
84.10%
-53.80M
241.46%
7.85M
114.59%
-11.48M
246.24%
5.57M
148.50%
8.33M
49.52%
cash at beginning of period
33.48M
-
20.85M
37.72%
15.20M
27.10%
43.46M
185.84%
17.63M
59.43%
38.29M
117.16%
76.32M
99.33%
22.52M
70.49%
30.37M
34.87%
18.89M
37.81%
24.46M
29.48%
cash at end of period
20.85M
-
15.20M
27.10%
43.46M
185.84%
17.63M
59.43%
38.29M
117.16%
76.32M
99.33%
22.52M
70.49%
30.37M
34.87%
18.89M
37.81%
24.46M
29.48%
32.79M
34.04%
operating cash flow
-86.06M
-
-69.75M
18.95%
-23.41M
66.43%
-75.89M
224.13%
-77.56M
2.20%
-58.83M
24.15%
-41.51M
29.44%
-52.19M
25.72%
5.88M
111.26%
-73.76M
1,354.81%
-5.74M
92.21%
capital expenditure
-1.22M
-
-413K
66.18%
-546K
32.20%
-804K
47.25%
-164K
79.60%
-1.11M
574.39%
-1.46M
31.56%
-1.26M
13.26%
-627K
50.32%
-450K
28.23%
-15M
3,233.33%
free cash flow
-87.28M
-
-70.17M
19.61%
-23.96M
65.85%
-76.69M
220.10%
-77.72M
1.34%
-59.93M
22.89%
-42.97M
28.31%
-53.45M
24.40%
5.25M
109.82%
-74.21M
1,513.22%
-20.74M
72.05%

All numbers in USD (except ratios and percentages)